Your browser doesn't support javascript.
loading
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate.
Chen, Wen-Hsiang; Chag, Shivali M; Poongavanam, Mohan V; Biter, Amadeo B; Ewere, Ebe A; Rezende, Wanderson; Seid, Christopher A; Hudspeth, Elissa M; Pollet, Jeroen; McAtee, C Patrick; Strych, Ulrich; Bottazzi, Maria Elena; Hotez, Peter J.
Afiliación
  • Chen WH; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Chag SM; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Poongavanam MV; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Biter AB; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Ewere EA; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Rezende W; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Seid CA; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Hudspeth EM; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Pollet J; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas 77030; Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of
  • McAtee CP; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030.
  • Strych U; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas 77030; Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of
  • Bottazzi ME; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas 77030; Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of
  • Hotez PJ; Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas 77030; Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of
J Pharm Sci ; 106(8): 1961-1970, 2017 08.
Article en En | MEDLINE | ID: mdl-28456726
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pichia / Vacunas Virales / Vacunas Sintéticas / Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo / Glicoproteína de la Espiga del Coronavirus Límite: Humans Idioma: En Revista: J Pharm Sci Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pichia / Vacunas Virales / Vacunas Sintéticas / Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo / Glicoproteína de la Espiga del Coronavirus Límite: Humans Idioma: En Revista: J Pharm Sci Año: 2017 Tipo del documento: Article